Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Ejhaem
|
July 3, 2026
Vitamin D Supplementation and Treatment-Free Survival in Early-Stage CLL: A Real-World Validation Study
Tamar Tadmor, Ronen Arbel, Talish Razi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
October 21, 2021
Dapagliflozin Versus Sacubitril-Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus
Ariel Hammerman, Joseph Azuri, Enis Aboalhasan, et al.
International Journal of Cardiology
|
July 9, 2016
PCSK9 inhibitors may improve cardiovascular outcomes-Can we afford them?
Ronen Arbel, Ariel Hammerman, Noa Triki, et al.
Clinical Drug Investigation
|
May 26, 2020
Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis
Ronen Arbel, Enis Aboalhasan, Ariel Hammerman, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Dapagliflozin vs. sacubitril-valsartan for prevention of heart failure events in non-diabetic patients with reduced ejection fraction: a cost per outcome analysis
Ronen Arbel, Enis Aboalhasan, Ariel Hammerman, et al.
Childhood Obesity (Print)
|
October 6, 2025
Adherence and Effectiveness of Liraglutide in Adolescents with Obesity
Shlomit Yaron, Ronen Arbel, Talish Razi, et al.
American Journal of Infection Control
|
December 31, 2021
How many lives do COVID vaccines save? Evidence from Israel
Ronen Arbel, Candace Makeda Moore, Ruslan Sergienko, et al.
Obesity (Silver Spring, Md.)
|
May 19, 2023
Liraglutide versus semaglutide for weight reduction-a cost needed to treat analysis
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, et al.
Diabetes, Obesity & Metabolism
|
December 12, 2022
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 3, 2025
Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines
Hadar Sadeh, Talish Razi, Ronen Arbel, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Ejhaem
|
July 3, 2026
Vitamin D Supplementation and Treatment-Free Survival in Early-Stage CLL: A Real-World Validation Study
Tamar Tadmor, Ronen Arbel, Talish Razi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
October 21, 2021
Dapagliflozin Versus Sacubitril-Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus
Ariel Hammerman, Joseph Azuri, Enis Aboalhasan, et al.
International Journal of Cardiology
|
July 9, 2016
PCSK9 inhibitors may improve cardiovascular outcomes-Can we afford them?
Ronen Arbel, Ariel Hammerman, Noa Triki, et al.
Clinical Drug Investigation
|
May 26, 2020
Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis
Ronen Arbel, Enis Aboalhasan, Ariel Hammerman, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Dapagliflozin vs. sacubitril-valsartan for prevention of heart failure events in non-diabetic patients with reduced ejection fraction: a cost per outcome analysis
Ronen Arbel, Enis Aboalhasan, Ariel Hammerman, et al.
Childhood Obesity (Print)
|
October 6, 2025
Adherence and Effectiveness of Liraglutide in Adolescents with Obesity
Shlomit Yaron, Ronen Arbel, Talish Razi, et al.
American Journal of Infection Control
|
December 31, 2021
How many lives do COVID vaccines save? Evidence from Israel
Ronen Arbel, Candace Makeda Moore, Ruslan Sergienko, et al.
Obesity (Silver Spring, Md.)
|
May 19, 2023
Liraglutide versus semaglutide for weight reduction-a cost needed to treat analysis
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, et al.
Diabetes, Obesity & Metabolism
|
December 12, 2022
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 3, 2025
Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines
Hadar Sadeh, Talish Razi, Ronen Arbel, et al.
Page
of 6